Bristol-Myers to Pay $11 Billion to License Cancer Drug
Prior: P: 235.7
New: N: -
Prior: Prior: 235.7
New: New: -
-
Prior: Prior: 6.98
New: New: -
Prior: Prior: 49
New: New: -
Latest News
- Prediction: This Artificial Intelligence (AI) Stock Will Be Worth More Than Apple By the End of 2025
- China's rare earth export curbs hit the auto industry worldwide
- Global Markets Rise, U.S. Futures Flat After Tech-Led Rally
- Trump’s Fight With Regulators Is About Who Watches the Watchers
- Remy Cointreau Pulls Long-Term Targets on Economic, Tariff Uncertainty
- Daily Spotlight: Argus Adjusts S&P 500 EPS Estimates